Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

30. April 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2770


	Artikel 1 - 20 / 55393

	PD-L1 levels, TP53 mutation profiles, and survival outcomes in pancreatic cancer differ by immune-nutritional status. World J Surg Oncol Li Z, Ren H, Zhang S, Sun C, Li Z, Niu P, Fei H, Xing C, Shi S, Zhao D. PMID: 40301983 [PubMed - indexed for MEDLINE]
	Artificial intelligence networks for assessing the prognosis of gastrointestinal cancer to immunotherapy based on genetic mutation features: a systematic review and meta-analysis. BMC Gastroenterol Norouzkhani N, Mobaraki H, Varmazyar S, Zaboli H, Mohamadi Z, Nikeghbali G, Bagheri K, Marivany N, Najafi M, Nozad Varjovi M, Abouzeid M, Zeidi Baghrabad H, Eini P, Azhdarimoghaddam A, Khosravi F, Asadi Anar M. PMID: 40301768 [PubMed - indexed for MEDLINE]
	CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer. BMC Gastroenterol Xi W, Liao W, Guo T, Jiang Q, Bai X, Wu X, Feng Y, Zhang S, Wu D, Wang Q, Yang A. PMID: 40301736 [PubMed - in process]
	Cyst Fluid Proteins Stratify Malignant Risk of Intraductal Papillary Mucinous Neoplasm of the Pancreas. Cancer Lett Liu C, Mosley A, Irajizad E, Yip-Schneider M, Wu H, Smith-Kinnaman WR, Tran T, Long JP, Do KA, Fahrmann J, DeWitt JM, Hanash S, Schmidt CM, Zhang J. PMID: 40300662 [PubMed - as supplied by publisher]
	Concurrent pancreatic ductal adenocarcinoma and poorly differentiated neuroendocrine carcinoma: A case report and review of the literature. Int J Surg Case Rep Negahi A, Zare-Mirzaie A, Negahban H, Soleymani S, Jaliliyan A, Agah S. PMID: 40300509 [PubMed - as supplied by publisher]
	Cadmium exposure and risk of pancreatic cancer: Systematic review and meta-analysis. PLoS One Soleimani Y, Nayebi M, Mahmoudi S, Daraei M, Khorsand S, Jahazi MA, Farsi MY, Khalafi F, Varseh M, Jarrahi ZM, Soleimani M, Massoudnia K, Karamian S, Jarrahi AM. PMID: 40299947 [PubMed - indexed for MEDLINE]
	Metagenomic Microbial Signatures for Noninvasive Detection of Pancreatic Cancer. Biomedicines Chen Y, Nian F, Chen J, Jiang Q, Yuan T, Feng H, Shen X, Dong L. PMID: 40299688 [PubMed]
	Neoadjuvant Chemotherapy vs Surgery First in a Rural Population With Resectable Pancreatic Cancer: Oncologic, Biologic, and Socioeconomic Implications. Am Surg Butare AF, Zervos EE. PMID: 40299460 [PubMed - as supplied by publisher]
	Can AI Be Useful in the Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes? Biomedicines Mejza M, Bajer A, Wanibuchi S, Ma. PMID: 40299428 [PubMed]
	High-Precision Intelligent Diagnosis of Pancreatic Cancer: Flowing Diffuseness from Single to Whole. Anal Chem Qi Y, Liu B, Shi J, Liu Y. PMID: 40296678 [PubMed - as supplied by publisher]
	Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis. Br J Surg Hamm JJM, van den Berg R, Andrinopoulou ER, Zwanenburg ES, Musters GD, Tanis PJ, Arjona-Sanchez A, COLOPEC and HIPECT4 Collaborator Groups. PMID: 40296220 [PubMed - indexed for MEDLINE]
	Risk factors, prognostic factors, and nomograms for liver metastasis in stage T(is)-T(2) colorectal cancer patients from a population-based study. Sci Rep Lin Z, Lin Z, Yi T, Liang Y, Mai Z, Li X, Zhong C, Wan Y, Li G. PMID: 40295692 [PubMed - indexed for MEDLINE]
	Temporal trends in cross-country inequalities of early-onset pancreatic cancer: a comprehensive analysis for the global burden of disease study 2021. Sci Rep Li L, Li J, Yan A, Xiang W, Gao W, Zhu H. PMID: 40295659 [PubMed - indexed for MEDLINE]
	The relationship between infectious pathogen antibodies, plasma metabolites, and breast cancer: A Mendelian randomization study with mediation analysis. Medicine (Baltimore) Wei J, Mo CD, Zhu GY, Qiu FY, Qin SP, Hou QY, Zhou Y, Wei WS, Huang Z, Yang JR. PMID: 40295253 [PubMed - indexed for MEDLINE]
	Survival and Chemotherapy in the Last 30 Days as a Quality Indicator for Pancreatic Cancer. Anticancer Res Solheim MM, Nieder C, Haukland EC. PMID: 40295073 [PubMed - indexed for MEDLINE]
	FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (GEMINI-PC-01). Br J Surg Tanaka H, Sakai A, Suenaga M, Hayashi M, Otsu T, Nakagawa N, Kurimoto K, Fukasawa M, Shibuya K, Watanabe N, Sunagawa M, Yamaguchi J, Mizuno T, Kokuryo T, Takami H, Ebata T, Fujii T, Kodera Y. PMID: 40294911 [PubMed - in process]
	Protease activity-based nanobiosensors for early detection of pancreatic cancer. Med Res Arch Covarrubias-Zambrano O, Agarwal D, Kalubowilage M, Ehsan S, Yapa AS, Covarrubias J, Kasi A, Natarajan B, Bossmann SH. PMID: 40292193 [PubMed]
	Constructing a neural network model based on tumor-infiltrating lymphocytes (TILs) to predict the survival of hepatocellular carcinoma patients. PeerJ Zhong W, Zhao Z, Fang X, Sun J, Wei Y, Li F, Han B, Jin C. PMID: 40292102 [PubMed - indexed for MEDLINE]
	Erratum: Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer: a systematic review and meta-analysis. Front Oncol Frontiers Production Office. PMID: 40291909 [PubMed]
	Current status and recent progress of nanomaterials in transcatheter arterial chemoembolization therapy for hepatocellular carcinoma. World J Clin Oncol Sun J, Li HL, Zhou WJ, Ma ZX, Huang XP, Li C. PMID: 40290691 [PubMed]

Artikel 1 - 20 / 55393

Seite 1 von 2770



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung